Dr Margie Smith has contributed to Chapter 8: Genetics and Epigenetics, Advanced Clinical Naturopathic Medicine.
Dr. Margie Smith is a Molecular Geneticist with over 30 years’ experience in Neuro-genetics and Cancer genetics. She has worked in major teaching hospitals in New Zealand and Australia. Specifically Margie developed diagnostic tests for families affected by early-onset Alzheimer’s disease and diagnostic screening for heritable breast and breast/ovarian cancer.
Working with an American based company Transgenomics Margie established high throughout genetic analysis using WAVE Technology. This enabled breast cancer screening to be used in diagnostic laboratories in Australia, New Zealand and Canada.
Margie has published in the areas of both cancer and neurogenetics and she has recently contributed to the publication Dementia.
In 2009, Margie became the co-founder of a Nutritional Genomics company called smartDNA. This company has established affordable, Predictive and Preventative Nutrition based genetic testing for practitioners and their clients. This Nutritional profiling is personalised and covers a number of health areas including cardiovascular profiling.
In 2014, smartDNA has developed a smart GUT Test looking at the human Microbiome. SmartDNA has developed the first curated human microbiome database in Australia for researchers and commercial entities to access.
Harlequin Publishing approached Dr. Margie Smith to write a book on Personalised Medicine and Nutritional Genomics for the general public. Gene Genius was published in September 2015.
Over two years ago smartDNA established smartLAB in the translational facility at Monash MHTP in Clayton. The laboratory offers a range of services from DNA extractions, Genomic Analysis, Clinical Trials, Bioinformatics, Product validation, Research and Development.
In 2019 smartDNA published its patent microbiome approach to diagnosing IBS subtypes and Autism. This will enable the identification of specific bacteria associated with each IBS subtype and those on the Autism spectrum. Importantly it enables continuous monitoring of the individual.